227 filings
Page 3 of 12
8-K
GRI
GRI Bio Inc
23 Aug 23
GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR
9:07am
4
David Leslie Szekeres
14 Aug 23
GRI BIO / David Leslie Szekeres ownership change
4:10pm
4
GRI
GRI Bio Inc
14 Aug 23
GRI BIO / CAMILLA V SIMPSON ownership change
4:07pm
4
Roelof Rongen
14 Aug 23
GRI BIO / Roelof Rongen ownership change
4:07pm
4
GRI
GRI Bio Inc
14 Aug 23
GRI BIO / David Charles Baker ownership change
4:06pm
10-Q
2023 Q2
GRI
GRI Bio Inc
Quarterly report
14 Aug 23
8:08am
8-K
GRI
GRI Bio Inc
14 Aug 23
On track to launch a Phase 2a biomarker study evaluating GRI-0621 for the treatment of IPF before year end 2023
8:06am
8-K
GRI
GRI Bio Inc
7 Jul 23
Submission of Matters to a Vote of Security Holders
4:03pm
8-K/A
GRI
GRI Bio Inc
6 Jul 23
Financial Statements and Exhibits
4:28pm
EFFECT
GRI
GRI Bio Inc
8 Jun 23
Notice of effectiveness
12:15am
424B3
GRI
GRI Bio Inc
7 Jun 23
Prospectus supplement
4:18pm
UPLOAD
GRI
GRI Bio Inc
5 Jun 23
Letter from SEC
12:00am
CORRESP
GRI
GRI Bio Inc
5 Jun 23
Correspondence with SEC
12:00am
S-3
GRI
GRI Bio Inc
Shelf registration
30 May 23
5:01pm
ARS
2022 FY
GRI
GRI Bio Inc
26 May 23
Annual report to shareholders
4:38pm
DEFA14A
GRI
GRI Bio Inc
26 May 23
Additional proxy soliciting materials
4:19pm
DEF 14A
GRI
GRI Bio Inc
Definitive proxy
26 May 23
4:16pm
8-K/A
GRI
GRI Bio Inc
26 May 23
Financial Statements and Exhibits
4:15pm
10-Q
2023 Q1
GRI
GRI Bio Inc
Quarterly report
15 May 23
5:01pm
SC 13G
Altium Capital Management LP
3 May 23
GRI BIO / Altium Capital Management ownership change
12:00am